Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PerkinElmer seals multiplex testing deal with Luminex :

This article was originally published in Clinica

Executive Summary

Wellesley, Massachusetts-based PerkinElmer has linked up with Luminex to develop technology for high-volume disease screening. It has licensed the Austin, Texas firm's xMAP multiplex testing know-how - which can perform multiple biomedical tests on a single sample - for use in the development of in vitro diagnostics in maternal, neonatal and prenatal health as well as for use in several areas of life science research. PerkinElmer also plans to standardise its multiplex assay development on the Luminex xMAP platform.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050667

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel